By comparison, semaglutide works on one receptor (GLP-1) while tirzepatide works on two receptors (GLP-1 and GIP)
The mechanism of action involves several physiological pathways that contribute to both glycemic control and weight loss
GLP-1 receptor agonists and gastrointestinal effects
As fat under the skin diminishes, previously hidden veins become more visible the disease has not necessarily progressed
The metabolic changes that occur as a result of diabetes (hyperinsulinemia, hyperglycemia, and dyslipidemia) potentiate signaling pathways and may increase the oncogenic nature of breast tissue through accelerating cell growth and migration, angiogenesis, increasing metastasis, and decreasing the response to chemotherapy (158, 244247)
Some clinics skipped labs altogether